These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 26956619)
41. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1. Kogut MH; Genovese KJ; He H Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653 [TBL] [Abstract][Full Text] [Related]
42. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Do MT; Kim HG; Choi JH; Jeong HG Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682 [TBL] [Abstract][Full Text] [Related]
43. Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras/Raf/MEK/ERK signaling. Wang Z; Ma L; Su M; Zhou Y; Mao K; Li C; Peng G; Zhou C; Shen B; Dou J Cell Death Dis; 2018 Feb; 9(2):217. PubMed ID: 29440765 [TBL] [Abstract][Full Text] [Related]
44. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras. Vasudevan KM; Burikhanov R; Goswami A; Rangnekar VM Cancer Res; 2007 Nov; 67(21):10343-50. PubMed ID: 17974977 [TBL] [Abstract][Full Text] [Related]
45. ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. Levidou G; Saetta AA; Gigelou F; Karlou M; Papanastasiou P; Stamatelli A; Kavantzas N; Michalopoulos NV; Agrogiannis G; Patsouris E; Korkolopoulou P World J Surg Oncol; 2012 Feb; 10():47. PubMed ID: 22376079 [TBL] [Abstract][Full Text] [Related]
46. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm. Phelps M; Phillips A; Darley M; Blaydes JP J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837 [TBL] [Abstract][Full Text] [Related]
47. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells. Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975 [TBL] [Abstract][Full Text] [Related]
48. Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling. Oh YT; Yue P; Zhou W; Balko JM; Black EP; Owonikoko TK; Khuri FR; Sun SY J Biol Chem; 2012 Jan; 287(1):257-267. PubMed ID: 22065586 [TBL] [Abstract][Full Text] [Related]
49. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Yang R; Piperdi S; Gorlick R Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278 [TBL] [Abstract][Full Text] [Related]
50. RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects. Kreeger PK; Mandhana R; Alford SK; Haigis KM; Lauffenburger DA Cancer Res; 2009 Oct; 69(20):8191-9. PubMed ID: 19789336 [TBL] [Abstract][Full Text] [Related]
51. Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells. Peng H; Li TW; Yang H; Moyer MP; Mato JM; Lu SC Am J Pathol; 2015 Apr; 185(4):1135-44. PubMed ID: 25794709 [TBL] [Abstract][Full Text] [Related]
52. Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis. Bigi A; Beltrami E; Trinei M; Stendardo M; Pelicci PG; Giorgio M Oncogene; 2016 Sep; 35(39):5132-43. PubMed ID: 26973251 [TBL] [Abstract][Full Text] [Related]
53. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis. Shi Y; Sahu RP; Srivastava SK BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491 [TBL] [Abstract][Full Text] [Related]
54. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080 [TBL] [Abstract][Full Text] [Related]
55. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882 [TBL] [Abstract][Full Text] [Related]
56. Constitutively active Ras negatively regulates Erk MAP kinase through induction of MAP kinase phosphatase 3 (MKP3) in NIH3T3 cells. Park YJ; Lee JM; Shin SY; Kim YH BMB Rep; 2014 Dec; 47(12):685-90. PubMed ID: 24602610 [TBL] [Abstract][Full Text] [Related]
57. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells. Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730 [TBL] [Abstract][Full Text] [Related]
58. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells. Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128 [TBL] [Abstract][Full Text] [Related]
59. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]